Daniel Mirmilshteyn

3M (United States)

Papers

1

Total Citations

6

H-Index

1

About

Daniel Mirmilshteyn’s research lies at the intersection of cancer nanomedicine and tumor microenvironment dynamics, with a focus on understanding how biophysical barriers limit drug delivery. His most cited work, “Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors” (2016, 6 citations), provides critical insights into the heterogeneous intra-tumoral accumulation of liposomal nanocarriers. By simultaneously mapping perfusion, interstitial fluid pressure (IFP), and liposome distribution, Mirmilshteyn demonstrated that chaotic tumor microcirculation and elevated IFP are key drivers of uneven drug delivery—a major obstacle to nanotherapy efficacy. This work bridges engineering and oncology, offering a spatial framework to optimize nanoparticle-based treatments. While his citation count reflects a focused, early-career impact, his contributions are foundational for researchers designing smarter delivery systems that overcome physiological resistance. Mirmilshteyn’s research underscores the importance of integrating tumor physiology with nanotechnology, paving the way for more effective, personalized cancer therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
6 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: 3M (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago